Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 27, 2026
Deep Learning Enables Automated Segmentation and Quantification of Ultrastructure from Transmission Electron Microscopy Images
Anqi Zou, Winston Tan, Jiayi Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer
Elisabeth I Heath, David W Hillman, Ulka Vaishampayan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 25, 2018
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
Ourania Nicolatou-Galitis, Maria Kouri, Erofili Papadopoulou, et al.
Ebiomedicine
|
April 9, 2020
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
Manish Kohli, Winston Tan, Tiantian Zheng, et al.
The Oncologist
|
April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
Prostate Cancer and Prostatic Diseases
|
June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients
Manish Kohli, Jian Li, Meijun Du, et al.
Cancer Research
|
May 20, 2016
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
Keith L Knutson, Raphael Clynes, Barath Shreeder, et al.
Blood Cancer Journal
|
October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2020
Management of Cancer Cachexia: ASCO Guideline
Eric J Roeland, Kari Bohlke, Vickie E Baracos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
April 27, 2026
Deep Learning Enables Automated Segmentation and Quantification of Ultrastructure from Transmission Electron Microscopy Images
Anqi Zou, Winston Tan, Jiayi Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer
Elisabeth I Heath, David W Hillman, Ulka Vaishampayan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 25, 2018
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
Ourania Nicolatou-Galitis, Maria Kouri, Erofili Papadopoulou, et al.
Ebiomedicine
|
April 9, 2020
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
Manish Kohli, Winston Tan, Tiantian Zheng, et al.
The Oncologist
|
April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
Prostate Cancer and Prostatic Diseases
|
June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients
Manish Kohli, Jian Li, Meijun Du, et al.
Cancer Research
|
May 20, 2016
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
Keith L Knutson, Raphael Clynes, Barath Shreeder, et al.
Blood Cancer Journal
|
October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2020
Management of Cancer Cachexia: ASCO Guideline
Eric J Roeland, Kari Bohlke, Vickie E Baracos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri, Jeff Sperinde, Heshan Liu, et al.
Page
of 9